Firefly Neuroscience (AIFF) Shares Outstanding (Diluted Average) (2010 - 2025)

Firefly Neuroscience has reported Shares Outstanding (Diluted Average) for 16 years, with the latest figure at $13.5 million in Q3 2025.

• For the quarter ending Q3 2025, Shares Outstanding (Diluted Average) rose 131.6% year-over-year to $13.5 million; the trailing twelve-month figure through Sep 2025 stood at $13.5 million (up 131.6% YoY), and the FY2024 full-year result was $5.8 million, changed N/A from the prior year.
• Shares Outstanding (Diluted Average) for Q3 2025 stood at $13.5 million, up from $5.8 million in the prior quarter.
• The five-year high for Shares Outstanding (Diluted Average) was $18.4 million in Q3 2022, with the low at $648498.0 in Q2 2023.
• Average Shares Outstanding (Diluted Average) over 5 years is $11.3 million, with a median of $12.6 million recorded in 2021.
• Year-over-year, Shares Outstanding (Diluted Average) plunged 96.45% in 2023 and soared 131.6% in 2025.
• Tracing AIFF's Shares Outstanding (Diluted Average) over 5 years: stood at $12.6 million in 2021, then soared by 46.19% to $18.4 million in 2022, then tumbled by 96.47% to $648498.0 in 2023, then jumped by 798.7% to $5.8 million in 2024, then soared by 131.6% to $13.5 million in 2025.
• The last three Shares Outstanding (Diluted Average) figures came in at $13.5 million (Q3 2025), $5.8 million (Q3 2024), and $671060.0 (Q2 2024), per Business Quant data.

Peer Comparison